查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1672082

全球医疗合约研究外包市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Healthcare Contract Research Outsourcing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球医疗保健合约研究外包市场规模预计将从 2024 年的 572.1 亿美元增长到 2033 年的 1075.8 亿美元，在 2026 年至 2033 年的预测期内呈现 7.27% 的强劲年复合成长率(CAGR)。

受临床研究和药物开发对高效且经济实惠的解决方案的需求不断增长的推动，医疗合约研究外包（CRO）市场有望大幅增长。随着製药和生技公司寻求简化营运流程、缩短新疗法的上市时间，对 CRO 的专业知识和资源的依赖也变得越来越普遍。随着各组织致力于增强其研究能力，市场对各种服务的需求激增，包括临床试验管理、资料分析和监管支援。

技术和资料管理的创新正在塑造医疗保健 CRO 市场的未来。进阶分析、人工智慧和机器学习的整合使 CRO 能够优化临床试验设计、改善患者招募并增强资料完整性。此外，分散临床试验和远端监控解决方案的兴起正在改变研究的进行方式，使得资料收集更加灵活、高效。随着监管环境的发展，CRO 越来越注重合规性和品质保证，以满足卫生当局的严格要求。

此外，医疗保健 CRO 市场将受益于 CRO、製药公司和学术机构之间加强合作，以促进创新并改善研究成果。随着情势的发展，重点将转向发展策略伙伴关係，利用每个利害关係人的优势，提高药物开发过程的整体效率。以患者为中心的方法和真实世界证据的重视也将在塑造医疗保健 CRO 服务的未来方面发挥关键作用，确保临床研究符合患者的需求和偏好。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

报告涵盖的细分

按服务

  • 临床试验服务
  • 监管服务
  • 临床数据管理和生物识别
  • 医学写作
  • 药物警戒
  • 站点管理协议
  • 其他的

按治疗领域

  • 肿瘤科/血液科
  • 细胞分裂素
  • 心血管/代谢
  • 呼吸系统
  • 传染病
  • 免疫学
  • 罕见疾病
  • 医疗设备
  • 其他的

按最终用户

  • 製药公司
  • 生技公司
  • 医疗器材公司
  • 学术机构和政府组织
  • 公司简介
  • Syneos 健康
  • 精鼎国际
  • ICON 集团
  • PRA 健康科学公司
  • 查尔斯河
  • 美国实验室控股公司（Covance）
  • 艾昆纬
  • 梅德佩斯
  • 医药产品开发有限公司。
  • 以上清单可以自订。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：医疗合约研究外包产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 各服务市场吸引力分析
    • 按治疗领域进行的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球医疗保健合约研究外包市场分析：按服务

  • 服务概览
  • 按服务进行的历史和预测资料分析
  • 临床试验服务
  • 监管服务
  • 临床数据管理和生物识别
  • 医学写作
  • 药物警戒
  • 站点管理协议
  • 其他的

第六章：全球医疗保健合约研究外包市场分析：依治疗领域

  • 按治疗领域概述
  • 按治疗领域分類的历史和预测数据分析
  • 肿瘤科/血液科
  • 细胞分裂素
  • 心血管/代谢
  • 呼吸系统
  • 传染病
  • 免疫学
  • 罕见疾病
  • 医疗设备
  • 其他的

第 7 章：全球医疗保健合约研究外包市场分析：按最终用户

  • 最终用户概览
  • 最终用户的历史和预测数据分析
  • 製药公司
  • 生技公司
  • 医疗器材公司
  • 学术机构和政府组织

第 8 章：全球医疗保健合约研究外包市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章：医疗合约研究外包公司的竞争格局

  • 医疗保健合约研究外包市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第十章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Syneos Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PAREXEL International
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ICON Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PRA Health Sciences Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Charles River
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Laboratory Corporation Of America Holdings (Covance)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • IQVIA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Medpace
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pharmaceutical Product Development LLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11215366

Global Healthcare Contract Research Outsourcing Market size is anticipated to grow from USD 57.21 Billion in 2024 to USD 107.58 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.27% during the forecast period of 2026 to 2033.

The healthcare contract research outsourcing (CRO) market is poised for substantial growth, driven by the increasing demand for efficient and cost-effective solutions in clinical research and drug development. As pharmaceutical and biotechnology companies seek to streamline their operations and reduce time-to-market for new therapies, the reliance on CROs for specialized expertise and resources is becoming more prevalent. The market is witnessing a surge in demand for a wide range of services, including clinical trial management, data analysis, and regulatory support, as organizations aim to enhance their research capabilities.

Innovations in technology and data management are shaping the future of the healthcare CRO market. The integration of advanced analytics, artificial intelligence, and machine learning is enabling CROs to optimize clinical trial designs, improve patient recruitment, and enhance data integrity. Additionally, the rise of decentralized clinical trials and remote monitoring solutions is transforming the way research is conducted, allowing for greater flexibility and efficiency in data collection. As regulatory environments evolve, CROs are increasingly focusing on compliance and quality assurance to meet the stringent requirements of health authorities.

Moreover, the healthcare CRO market will benefit from increased collaboration between CROs, pharmaceutical companies, and academic institutions to foster innovation and improve research outcomes. As the landscape evolves, the focus will shift towards developing strategic partnerships that leverage the strengths of each stakeholder, enhancing the overall efficiency of the drug development process. The emphasis on patient-centric approaches and real-world evidence will also play a crucial role in shaping the future of healthcare CRO services, ensuring that clinical research aligns with the needs and preferences of patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Service

  • Clinical Trial Service
  • Regulatory Service
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Pharmacovigilance
  • Site Management Protocol
  • Others

By Therapeutic Area

  • Oncology / Hematology
  • CNs
  • CV/Metabolic
  • Respiratory
  • Infectious Diseases
  • Immunology
  • Rare Diseases
  • Medical Devices
  • Others

By End-user

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government Organizations
  • COMPANIES PROFILED
  • Syneos Health
  • PAREXEL International
  • ICON plc
  • PRA Health Sciences Inc.
  • Charles River
  • Laboratory Corporation of America Holdings (Covance)
  • IQVIA
  • Medpace
  • Pharmaceutical Product Development LLC.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY SERVICE

  • 5.1. Overview By Service
  • 5.2. Historical and Forecast Data Analysis By Service
  • 5.3. Clinical Trial Service Historic and Forecast Sales By Regions
  • 5.4. Regulatory Service Historic and Forecast Sales By Regions
  • 5.5. Clinical Data Management & Biometrics Historic and Forecast Sales By Regions
  • 5.6. Medical Writing Historic and Forecast Sales By Regions
  • 5.7. Pharmacovigilance Historic and Forecast Sales By Regions
  • 5.8. Site Management Protocol Historic and Forecast Sales By Regions
  • 5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1. Overview By Therapeutic Area
  • 6.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 6.3. Oncology / Hematology Historic and Forecast Sales By Regions
  • 6.4. CNs Historic and Forecast Sales By Regions
  • 6.5. CV/Metabolic Historic and Forecast Sales By Regions
  • 6.6. Respiratory Historic and Forecast Sales By Regions
  • 6.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 6.8. Immunology Historic and Forecast Sales By Regions
  • 6.9. Rare Diseases Historic and Forecast Sales By Regions
  • 6.10. Medical Devices Historic and Forecast Sales By Regions
  • 6.11. Others Historic and Forecast Sales By Regions

7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.4. Biotechnology Companies Historic and Forecast Sales By Regions
  • 7.5. Medical Device Companies Historic and Forecast Sales By Regions
  • 7.6. Academic Institutes & Government Organizations Historic and Forecast Sales By Regions

8. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HEALTHCARE CONTRACT RESEARCH OUTSOURCING COMPANIES

  • 9.1. Healthcare Contract Research Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Syneos Health
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. PAREXEL International
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. ICON Plc
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. PRA Health Sciences Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Charles River
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Laboratory Corporation Of America Holdings (Covance)
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IQVIA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Medpace
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Pharmaceutical Product Development LLC
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service (USD MN)
  • Clinical Trial Service Market Sales By Geography (USD MN)
  • Regulatory Service Market Sales By Geography (USD MN)
  • Clinical Data Management & Biometrics Market Sales By Geography (USD MN)
  • Medical Writing Market Sales By Geography (USD MN)
  • Pharmacovigilance Market Sales By Geography (USD MN)
  • Site Management Protocol Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology / Hematology Market Sales By Geography (USD MN)
  • CNs Market Sales By Geography (USD MN)
  • CV/Metabolic Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Medical Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic Institutes & Government Organizations Market Sales By Geography (USD MN)
  • Global Healthcare Contract Research Outsourcing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Healthcare Contract Research Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Healthcare Contract Research Outsourcing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service (USD MN)
  • Clinical Trial Service Market Sales By Geography (USD MN)
  • Regulatory Service Market Sales By Geography (USD MN)
  • Clinical Data Management & Biometrics Market Sales By Geography (USD MN)
  • Medical Writing Market Sales By Geography (USD MN)
  • Pharmacovigilance Market Sales By Geography (USD MN)
  • Site Management Protocol Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology / Hematology Market Sales By Geography (USD MN)
  • CNs Market Sales By Geography (USD MN)
  • CV/Metabolic Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Medical Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic Institutes & Government Organizations Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.